The impact of pre‐existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults

Abstract Age‐associated immune changes and pre‐existing influenza immunity are hypothesized to reduce influenza vaccine effectiveness in older adults, although the contribution of each factor is unknown. Here, we constructed influenza‐specific IgG landscapes and determined baseline concentrations of cytokines typically associated with chronic inflammation in older adults (TNF‐α, IL‐10, IL‐6, and IFN‐γ) in 30 high and 29 low influenza vaccine responders (HR and LR, respectively). In a background of high H3 antibody titers, vaccine‐specific H3, but not H1, antibody titers were boosted in LRs to titers comparable to HRs. Pre‐vaccination concentrations of IL‐10 were higher in LRs compared with HRs and inversely correlated with titers of pre‐existing influenza antibodies. Baseline TNF‐α concentrations were positively correlated with fold‐increases in antibody titers in HRs. Our findings indicate that baseline inflammatory status is an important determinant for generating post‐vaccination hemagglutinin‐inhibition antibodies in older adults, and IgG responses can be boosted in the context of high pre‐existing immunity.

[1]  Francisco A. Chaves,et al.  The negative effect of pre-existing immunity on influenza vaccine responses transcends the impact of vaccine formulation type and vaccination history. , 2022, The Journal of infectious diseases.

[2]  Min Kang,et al.  Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific , 2022, Vaccines.

[3]  R. Webby,et al.  Activated CD4+ T cells and CD14hiCD16+ monocytes correlate with antibody response following influenza virus infection in humans , 2021, Cell reports. Medicine.

[4]  Karlynn E. Neu,et al.  Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans , 2020, Science Translational Medicine.

[5]  S. Way,et al.  IL-10–producing Tfh cells accumulate with age and link inflammation with age-related immune suppression , 2020, Science Advances.

[6]  Kimihito Ito,et al.  Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults , 2020, mBio.

[7]  L. Rosella,et al.  The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  R. Kennedy,et al.  Immunosenescence and human vaccine immune responses , 2019, Immunity & Ageing.

[9]  B. Cowling,et al.  The effect of influenza vaccination history on changes in hemagglutination inhibition titers following receipt of the 2015/16 influenza vaccine in older adults in Hong Kong. , 2019, The Journal of infectious diseases.

[10]  D. Stevenson,et al.  High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine , 2018, The Journal of infectious diseases.

[11]  C. Franceschi,et al.  Inflammaging: a new immune–metabolic viewpoint for age-related diseases , 2018, Nature Reviews Endocrinology.

[12]  J. Peiris,et al.  Age-specific differences in the dynamics of protective immunity to influenza , 2018, Nature Communications.

[13]  S. Trottier,et al.  The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People , 2017, The Journal of infectious diseases.

[14]  M. Eichelberger,et al.  Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin , 2017, mBio.

[15]  T. Tumpey,et al.  Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans , 2017, Clinical and Vaccine Immunology.

[16]  K. Wieczorowska-Tobis,et al.  Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study , 2016, Immunity & Ageing.

[17]  Rustom Antia,et al.  Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza , 2016, PLoS pathogens.

[18]  J. Powers,et al.  Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model , 2016, mBio.

[19]  P. Palese,et al.  Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans , 2016, mBio.

[20]  Patrick C. Wilson,et al.  Immune history profoundly affects broadly protective B cell responses to influenza , 2015, Science Translational Medicine.

[21]  R. Ahmed,et al.  Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[22]  W. Cao,et al.  Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses , 2015, Open forum infectious diseases.

[23]  Samit R. Joshi,et al.  Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. , 2015, The Journal of infectious diseases.

[24]  M. Eichelberger,et al.  An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera. , 2014, Journal of virological methods.

[25]  Malika Charrad,et al.  NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set , 2014 .

[26]  K. Stiasny,et al.  Tick-Borne Encephalitis (TBE) and Hepatitis B Nonresponders Feature Different Immunologic Mechanisms in Response to TBE and Influenza Vaccination with Involvement of Regulatory T and B Cells and IL-10 , 2013, The Journal of Immunology.

[27]  A. Díaz,et al.  Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season , 2013, Immunity & Ageing.

[28]  C. Weyand,et al.  Understanding immunosenescence to improve responses to vaccines , 2013, Nature Immunology.

[29]  M. Pahor,et al.  Interleukin‐6, C‐Reactive Protein, and Tumor Necrosis Factor‐Alpha as Predictors of Mortality in Frail, Community‐Living Elderly Individuals , 2011, Journal of the American Geriatrics Society.

[30]  L. Fried,et al.  Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. , 2011, Vaccine.

[31]  Harry B. Greenberg,et al.  Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses , 2008, PloS one.

[32]  T. Strandberg,et al.  Frailty in elderly people , 2007, The Lancet.

[33]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[34]  A. Hampson,et al.  Antibody response to one and two doses of influenza virus subunit vaccine. , 1976, The Medical journal of Australia.

[35]  D. Hobson,et al.  Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity. , 1973, Lancet.